Avricore Health Inc. Files 6-K Report
Ticker: AVCRF · Form: 6-K · Filed: Jul 9, 2024 · CIK: 1355736
| Field | Detail |
|---|---|
| Company | Avricore Health INC. (AVCRF) |
| Form Type | 6-K |
| Filed Date | Jul 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
Related Tickers: AVCR
TL;DR
AVRICORE HEALTH (AVCR) filed its 6-K for June 30, 2024. Standard foreign private issuer report.
AI Summary
Avricore Health Inc. filed a Form 6-K on July 9, 2024, for the reporting period ending June 30, 2024. The company, formerly known as Vanc Pharmaceuticals Inc., NUVA Pharmaceuticals Inc., and ALDA Pharmaceuticals Corp., is based in Vancouver, BC. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides an update on the company's status as a foreign private issuer for the reporting period, which is important for investors tracking regulatory disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Avricore Health Inc. (company) — Registrant
- Vanc Pharmaceuticals Inc. (company) — Former company name
- NUVA Pharmaceuticals Inc. (company) — Former company name
- ALDA Pharmaceuticals Corp. (company) — Former company name
- 20240630 (date) — Reporting period end date
- 20240709 (date) — Filing date
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2024.
What is Avricore Health Inc.'s central index key (CIK)?
Avricore Health Inc.'s CIK is 0001355736.
When was Avricore Health Inc. previously known by other names?
The company was formerly known as Vanc Pharmaceuticals Inc. (name change 20140911), NUVA Pharmaceuticals Inc. (name change 20140110), and ALDA Pharmaceuticals Corp. (name change 20060309).
What is the principal executive office address for Avricore Health Inc.?
The principal executive office is located at 1120-789 West Pender St, Vancouver, BC, V6C 1H2.
What is the fiscal year end for Avricore Health Inc.?
The fiscal year end for Avricore Health Inc. is December 31 (1231).
Filing Stats: 380 words · 2 min read · ~1 pages · Grade level 17.3 · Accepted 2024-07-09 06:05:04
Filing Documents
- form6-k.htm (6-K) — 19KB
- ex1.htm (EX-1) — 41KB
- ex1_001.jpg (GRAPHIC) — 10KB
- 0001493152-24-026555.txt ( ) — 75KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AVRICORE HEALTH INC. Date: July 9, 2024 By “Kiki Smith” Kiki Smith Chief Financial Officer SEC1815(04-09) Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number